Aaron Seth Kesselheim

Publications

• Generic but Expensive: Why Prices Can Remain High for Off-Patent Drugs
  71 UC L.J. 1019 (2020) · UC Law Journal · 2020
• Reputation and Authority: The FDA and the Fight over U.S. Prescription Drug Importation
  73 VAND. L. REV. 1331 (2020) · Vanderbilt Law Review · 2020
• Transformative Models to Promote Prescription Drug Innovation and Access: A Landscape Analysis
  19 YALE J. HEALTH POL'Y L. & ETHICS (2020) · Yale Journal of Health Policy, Law, and Ethics · 2020

• 2018 Stuart Rome Lecture: Origins of and Potential Solutions to High Prescription Drug Prices in the U.S.
  22 J. HEALTH CARE L. & POL'Y 1 (2019) · Journal of Health Care Law and Policy · 2019
• Hatch-Waxman Turns 30: Do We Need a Re-Designed Approach for the Modern Era?
  15 YALE J. HEALTH POL'Y L. & ETHICS (2015) · Yale Journal of Health Policy, Law, and Ethics · 2015
• Prospects for Regulation of Off-label Promotion in an Era of Expanding Commercial Speech Protection
  92 N. C. L. REV. 1539 (2014) · North Carolina Law Review · 2014
• Improving Antibiotic Markets for Long Term Sustainability
  11 YALE J. HEALTH POL'Y L. & ETHICS 101 (2013) · Yale Journal of Health Policy, Law, and Ethics · 2013

• The Swinging Pendulum: The Supreme Court Reverses Course on ERISA and Managed Care
  5 YALE J. HEALTH POL'Y L. & ETHICS 451 (2008) · Yale Journal of Health Policy, Law, and Ethics · 2008
• What's the Appeal--Trying to Control Managed Care Medical Necessity Decisionmaking through a System of External Appeals
  149 U. PENN. L. REV. 873 (2001) · University of Pennsylvania Law Review · 2001